Author
N. Tavares
Recent research
- Health & MedicineOpen access
Real-World Safety Profile of Adjuvant Abemaciclib in HR+/HER2− Early Breast Cancer
Background/Objectives: Treatment with adjuvant abemaciclib plus endocrine therapy (ET) has been demonstrated to improve outcomes in patients with HR+/HER2- early breast cancer at high risk of recurrence. However, real-world data regarding abemaciclib tolerability and treatment ma...